Helius Medical Technologies(HSDT) Newsfilter·2024-05-20 13:00Core Insights - Helius Medical Technologies has received approval for its Portable Neuromodulation Stimulator (PoNS®) device to be included in the Veterans Affairs (VA) Federal Supply Schedule and GSA Advantage contracts, providing access to U.S. veterans and government employees suffering from gait and balance impairments due to multiple sclerosis (MS) [1][4] Product and Pricing - The PoNS system is priced at 7,344.97, and it is indicated for short-term treatment of gait deficits in adults with mild-to-moderate MS symptoms when used alongside physical therapy [2] - The device is designed to deliver neurostimulation through a mouthpiece and is primarily used at home in conjunction with physical rehabilitation exercises [7] Market Potential - The VA estimates that between 55,000 and 70,000 veterans in the U.S. are living with MS, indicating a significant potential market for the PoNS device [3] - The inclusion of PoNS on the FSS Med/Surg and GSA Advantage marketplace is expected to facilitate quicker access to this therapy for veterans and federal employees [4] Company Background - Helius Medical Technologies focuses on neurologic deficits and aims to improve the lives of individuals dealing with neurologic diseases through its innovative technology platform [6] - Lovell Government Services, a partner of Helius, has a strong track record in introducing suppliers to the government market and aims to enhance federal revenue streams for medical and pharmaceutical companies [5]